Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 3,573 | 3,397 | 3,213 | 3,442 | 6,444 |
| Cost of Goods | 889 | 7 | 84 | 6 | 160 |
| Gross Profit | 2,684 | 3,389 | 3,130 | 3,436 | 6,284 |
| Operating Expenses | 21,456 | 15,830 | 15,365 | 15,230 | 19,120 |
| Operating Income | -17,884 | -12,434 | -12,152 | -11,788 | -12,676 |
| Other Income | 990 | 24 | 1 | 1 | 11 |
| Pre-tax Income | -16,894 | -12,410 | -12,151 | -11,788 | -12,665 |
| Net Income Continuous | -16,894 | -12,410 | -12,151 | -11,788 | -12,665 |
| Net Income | $-16,894 | $-12,410 | $-12,151 | $-11,788 | $-12,665 |
| EPS Basic Total Ops | -0.17 | -0.13 | -0.13 | -0.13 | -0.12 |
| EPS Basic Continuous Ops | -0.17 | -0.13 | -0.13 | -0.13 | -0.13 |
| EPS Diluted Total Ops | -0.17 | -0.13 | -0.13 | -0.13 | -0.12 |
| EPS Diluted Continuous Ops | -0.17 | -0.13 | -0.13 | -0.13 | -0.13 |
| EBITDA(a) | $-17,540 | $-12,069 | $-11,763 | $-11,378 | $-12,281 |